Wang Mei, Ding Jing-juan, Liu Yue-hui
Department of Infectious Diseases, Guiyang Medical College, Guiyang 550004, China.
Zhonghua Gan Zang Bing Za Zhi. 2007 Feb;15(2):98-102.
To study the relationships between hepatitis B virus (HBV ) pre-S region mutations and their genotypes and the stages of liver disease of the patients.
The entire HBV pre-S1 and pre-S2 genes were amplified by polymerase chain reaction (PCR). The amplified products were digested by NlaIII restriction enzyme. A detecting method for pre-S2 start codon mutation was established according to the restriction fragment length polymorphism (RFLP) analysis. Pre-S region deletion was revealed by polyacrylamide gel electrophoresis (PAGE). Fourteen sera having pre-S deletions or pre-S2 start codon mutations and wild strains were directly sequenced. HBV genotypes were determined by RFLP based on S-gene PCR products. One hundred sixty serum samples were collected from patients with HBV related diseases and they were determined by the above methods. The relationships between HBV pre-S region mutations and their genotypes and the stages of liver disease of the patients were analysed.
Of the 160 sera, genotype B and C were identified in 81 and 79 respectively. The detected ratios of pre-S2 start codon and pre-S deletion mutations were significantly higher in genotype C than in genotype B (43.04% vs 1.23%, 36.71% vs 19.75%, P<0.05, respectively). The detection rates of pre-S2 start codon mutation were significantly different in different groups: from 50.00% (HCC), 39.47% (LC), 8.00% (CH), to ASC (0). The detection rates of pre-S deletion mutations among patients with HCC (53.13%), LC (42.11%), CH (18.00%) and ASC (7.50%) also varied significantly. The results obtained from sequencing and PCR-RFLP/PAGE were completely compatible. Multivariate analysis indicated that genotype C (OR=6.26, P<0.01) and advanced liver disease (OR=11.99, P<0.01) were significant variables for pre-S mutations development.
The pre-S2 start codon and pre-S deletion mutations are more common in genotype C than in genotype B. These mutations are closely related to the progression of liver disease.
研究乙型肝炎病毒(HBV)前S区突变及其基因型与患者肝病分期之间的关系。
采用聚合酶链反应(PCR)扩增整个HBV前S1和前S2基因。扩增产物用NlaIII限制性内切酶消化。根据限制性片段长度多态性(RFLP)分析建立前S2起始密码子突变检测方法。通过聚丙烯酰胺凝胶电泳(PAGE)揭示前S区缺失。对14份有前S区缺失或前S2起始密码子突变的血清及野生株进行直接测序。基于S基因PCR产物,通过RFLP确定HBV基因型。收集160例HBV相关疾病患者的血清样本,并用上述方法进行检测。分析HBV前S区突变及其基因型与患者肝病分期之间的关系。
160份血清中,分别鉴定出81份B基因型和79份C基因型。C基因型中前S2起始密码子和前S区缺失突变的检出率显著高于B基因型(分别为43.04%对1.23%,36.71%对19.75%,P<0.05)。前S2起始密码子突变的检出率在不同组间有显著差异:肝癌(HCC)组为50.00%,肝硬化(LC)组为39.47%,慢性肝炎(CH)组为8.00%,无症状携带者(ASC)组为0。HCC患者(53.13%)、LC患者(42.11%)、CH患者(18.00%)和ASC患者(7.50%)的前S区缺失突变检出率也有显著差异。测序结果与PCR-RFLP/PAGE结果完全相符。多因素分析表明,C基因型(OR=6.26,P<0.01)和晚期肝病(OR=11.99,P<0.01)是前S区突变发生的显著变量。
前S2起始密码子和前S区缺失突变在C基因型中比在B基因型中更常见。这些突变与肝病进展密切相关。